HealthEquity Inc (HQY)

In the past six months, HealthEquity's stock has risen by 9.5%, outperforming its industry's 3.2% growth but underperforming the S&P 500's 27.6% increase. The company reported strong second-quarter fiscal 2026 results, driven by growth in HSAs, with total HSAs reaching 10 million and HSA assets growing to $33.1 billion. Net income and Adjusted EBITDA increased significantly, achieving record gross and near-record adjusted EBITDA margins, leading to raised fiscal 2026 guidance. In the first quarter of fiscal 2026, HealthEquity also reported strong revenue and earnings growth, margin expansion, and operating leverage. As of November 20, 2025, the stock price was $100.77 per share, a decline of 3.71% from the previous year. The stock has shown stable price volatility. A decline in stock price was attributed to expectations of interest rate cuts, but management has taken steps to mitigate this. HealthEquity is also making progress in its AI and mobile-first transformation.

While explicit details are limited, HealthEquity experiences some level of seasonality, with September 2025 noted as a seasonally weak time. The company operates in the healthcare savings field, which has a large addressable market and benefits from secular healthcare tailwinds. Demand for health savings accounts and other consumer-directed benefits is generally driven by employer offerings and individual healthcare planning, which may have some cyclical patterns related to benefit enrollment periods.

HealthEquity, Inc. is a technology-enabled services company providing integrated solutions for healthcare account management, helping consumers make informed healthcare saving and spending decisions. The company operates in the Medical sector, specifically in Health Information Services and Healthcare Providers & Services. Its flagship product is the Health Savings Account (HSA), a tax-advantaged financial account. HealthEquity also offers consumer-directed benefits (CDBs) like FSAs, HRAs, and COBRA services, along with an investment platform and pre-tax commuter benefit programs.

HealthEquity, Inc. primarily generates revenue and provides its technology-enabled services platforms to consumers and employers in the United States. The company is headquartered in Draper, Utah.

HealthEquity's brand reputation is positively influenced by its focus on customer satisfaction and technological advancements, leveraging AI to enhance services and increase member satisfaction. The AI-powered claims adjudication system processes reimbursements faster, and the secure mobile app and passkey authentication enhance security and engagement. The company aims to make HSAs as widespread as 401(k)s and IRAs by 2030. Data security threats are a major concern, and HealthEquity has devoted resources to cybersecurity and privacy programs, implementing measures to comply with regulations.

Approximately 98.2% of HealthEquity, Inc.'s shares are held by institutions, with individual insiders owning about 1.71%. Other sources indicate institutional investors own between 52.74% and 77.68% of the stock, with insiders holding around 2.14%, and public companies and individual investors owning 20.18% to 24.94%. Major institutional shareholders include BlackRock, Inc., Vanguard Group Inc, Wasatch Advisors Inc, Fmr Llc, State Street Corp, Geode Capital Management, Llc, and Invesco Ltd. Westfield Capital Management Co. LP notably boosted its position in HealthEquity during the second quarter of 2025.